SHC-alpha5beta1 integrin interactions regulate breast cancer cell adhesion and motility

Area of Science:

• Molecular Biology
• Cell Biology
• Oncology

Background:

• SHC proteins are key signaling substrates for tyrosine kinases (TKs).
• Elevated tyrosine phosphorylated SHC is observed in tumor cells overexpressing TKs.
• The role of amplified SHC signaling in breast cancer development and metastasis is not well understood.

Purpose of the Study:

• To investigate the significance of SHC overexpression in breast tumorigenesis and metastasis.
• To determine how amplified SHC signaling affects cell interactions with fibronectin (FN).

Main Methods:

• Utilized human breast cancer cell lines with SHC overexpression (MCF-7/SHC) and control cell lines.
• Assessed cell adhesion, spreading, growth, and motility on fibronectin.
• Analyzed the association of SHC with alpha5beta1 integrin.
• Measured adhesion-dependent MAP kinase activity and cell locomotion in response to growth factors (EGF, IGF-I).

Main Results:

• Seven- to ninefold SHC overexpression altered cell interactions with fibronectin.
• Increased SHC association with alpha5beta1 integrin, accelerated spreading on FN, and reduced basal growth on FN were observed in MCF-7/SHC cells.
• Adhesion-dependent MAP kinase activity declined early, and basal motility on FN was inhibited.
• Locomotion was significantly stimulated by EGF or IGF-I in MCF-7/SHC cells compared to controls.

Conclusions:

• SHC plays a role in regulating cell adhesion and motility on fibronectin in breast cancer cells.
• Amplified SHC signaling influences cell behavior in response to the extracellular matrix and growth factors.
• These findings suggest SHC as a potential mediator in breast cancer progression.